Clinical Trials Browser

Interventional × Neurilemmoma × 1 year × Clear all

NCT01083966 2026-06-01

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Phase 1 Suspended

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic

NCT05684692 2026-04-23

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Phase 2 Recruiting

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

NCT04278118 2026-02-17

HiPPI

Phase NA Recruiting

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

Phase NA Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Phase 2 Completed

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT02282917 2025-12-05

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Phase EARLY_PHASE1 Terminated

7 enrolled 19 charts

Meningioma, Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2